NERYNVA
Dead / Abandoned — Abandoned — no statement of use filed (as of 25 Jan 2021)
What this means for you
This application is over — abandoned 25 Jan 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88492501
- Mark type
- Stylized text
- Filed
- 27 Jun 2019
- Published for opposition
- 29 Oct 2019
- Abandoned
- 25 Jan 2021
- Attorney of record
- Ann K. Ford
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of stroke; pharmaceuticals for the treatment of neurological disease, pharmaceuticals for the treatment of ischemia, pharmaceuticals for the treatment of neuronal injury, and pharmaceuticals for the treatment of neurodegenerative diseases; pharmaceuticals and pharmaceutical preparations for the treatment of subarachnoid hemorrhage, strokes associated with vascular interventions, traumatic brain injury, surgical brain injuries, radiation-induced brain injuries, concussions, pain, anxiety, epilepsy, neuronal damage associated with epilepsy, Alzheimer's, tinnitus, retinal ischemia, Parkinson's disease, Huntington's disease, Amyotrophic Lateral Sclerosis
Owner
Prosecution history
- 25 Jan 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 25 Jan 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 25 Jun 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2020 — SOU EXTENSION 1 GRANTED
- 23 Jun 2020 — SOU EXTENSION 1 FILED
- 23 Jun 2020 — SOU TEAS EXTENSION RECEIVED
- 24 Dec 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Oct 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Oct 2019 — PUBLISHED FOR OPPOSITION
- 09 Oct 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Sept 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Sept 2019 — ASSIGNED TO EXAMINER
- 09 Jul 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Jul 2019 — NEW APPLICATION ENTERED